Pinebridge Investments L.P. Has $18.83 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Pinebridge Investments L.P. trimmed its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 17.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,895 shares of the company's stock after selling 52,270 shares during the quarter. Pinebridge Investments L.P. owned about 0.05% of GE HealthCare Technologies worth $18,833,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Cherry Creek Investment Advisors Inc. lifted its position in GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after purchasing an additional 114 shares during the period. Independence Bank of Kentucky lifted its position in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after purchasing an additional 114 shares during the period. Haverford Trust Co lifted its position in GE HealthCare Technologies by 2.4% during the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company's stock worth $383,000 after purchasing an additional 115 shares during the period. Tandem Capital Management Corp ADV lifted its position in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after purchasing an additional 118 shares during the period. Finally, Arcus Capital Partners LLC lifted its position in GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after purchasing an additional 119 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 0.3 %

NASDAQ GEHC traded down $0.20 during mid-day trading on Tuesday, reaching $67.87. 2,715,873 shares of the stock were exchanged, compared to its average volume of 3,265,102. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a 50 day simple moving average of $76.10 and a 200-day simple moving average of $81.91. The stock has a market cap of $31.07 billion, a P/E ratio of 15.66, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.21%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several recent analyst reports. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Piper Sandler dropped their price objective on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus price target of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.